4DMedical (ASX:4DX) Debt-to-Revenue : 2.87 (As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is 4DMedical Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

4DMedical's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was A$0.65 Mil. 4DMedical's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was A$3.91 Mil. 4DMedical's annualized Revenue for the quarter that ended in Dec. 2023 was A$1.59 Mil. 4DMedical's annualized Debt-to-Revenue for the quarter that ended in Dec. 2023 was 2.87.

4DMedical Debt-to-Revenue Historical Data

The historical data trend for 4DMedical's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

4DMedical Debt-to-Revenue Chart

4DMedical Annual Data

Trend

Jun21

Jun22

Jun23

Debt-to-Revenue

7.78

5.92

18.22

4DMedical Semi-Annual Data
	Dec19	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Debt-to-Revenue	Get a 7-Day Free Trial			4.14	3.47	5.87	N/A	2.87

Competitive Comparison of 4DMedical's Debt-to-Revenue

For the Medical Devices subindustry, 4DMedical's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

4DMedical's Debt-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, 4DMedical's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where 4DMedical's Debt-to-Revenue falls into.

4DMedical Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

4DMedical's Debt-to-Revenue for the fiscal year that ended in Jun. 2023 is calculated as

Debt-to-Revenue	=	Total Debt			/	Revenue
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Revenue
	=	(0.933	+	4.206)	/	0.282
	=	18.22

4DMedical's annualized Debt-to-Revenue for the quarter that ended in Dec. 2023 is calculated as

Debt-to-Revenue	=	Total Debt			/	Revenue
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Revenue
	=	(0.647	+	3.908)	/	1.586
	=	2.87

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is two times the quarterly (Dec. 2023) Revenue data.

4DMedical Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of 4DMedical's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

4DMedical (ASX:4DX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » 4DMedical Ltd (ASX:4DX) » Definitions » Debt-to-Revenue

Comparable Companies

Traded in Other Exchanges

FDMDF:USA

Address

700 Swanston Street, Level 7, Melbourne Connect, Carlton, VIC, AUS, 3053

Website

https://www.4dmedical.com

4DMedical Ltd is a company whose principal activities is medical research technology and the development of a non?invasive respiratory imaging solution using four?dimensional imaging. The four-dimensional lung imaging technology utilises mathematics models and algorithms to convert X-ray scans into quantitative data which helps the physicians to manage patients with respiratory diseases and diseases of the lung.

4DMedical (ASX:4DX) Headlines

No Headlines